Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 35,559Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Alliance revenue - Lenvima

02 6Lenvima

03 4Lenvima

04 2Lenvima/Kisplyx

PharmaCompass

01

Brand Name : Lenvima

Lenvatinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Lenvima

arrow
Pharmtech & Ingredients
Not Confirmed

Lenvatinib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 1,283

2019 Revenue in Millions : 947

Growth (%) : 35

blank

02

Brand Name : Lenvima

Lenvatinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Lenvima

arrow
Pharmtech & Ingredients
Not Confirmed

Lenvatinib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 580

2019 Revenue in Millions : 404

Growth (%) : 44

blank

03

Brand Name : Lenvima

Lenvatinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Lenvima

arrow
Pharmtech & Ingredients
Not Confirmed

Lenvatinib

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 704

2020 Revenue in Millions : 580

Growth (%) : 21

blank

04

Brand Name : Lenvima

Lenvatinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Lenvima

arrow
Pharmtech & Ingredients
Not Confirmed

Lenvatinib

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 1,445

2020 Revenue in Millions : 1,230

Growth (%) : 27

blank

05

Brand Name : Lenvima

Lenvatinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Lenvima

arrow
Pharmtech & Ingredients
Not Confirmed

Lenvatinib

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 876

2021 Revenue in Millions : 704

Growth (%) : 24

blank

06

Brand Name : Lenvima/Kisplyx

Lenvatinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Lenvima/Kisplyx

arrow
Pharmtech & Ingredients
Not Confirmed

Lenvatinib

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 1,848

2021 Revenue in Millions : 1,445

Growth (%) : 28

blank

07

Brand Name : Lenvima/Kisplyx

Lenvatinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Lenvima/Kisplyx

arrow
Pharmtech & Ingredients
Not Confirmed

Lenvatinib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 1,909

2022 Revenue in Millions : 1,848

Growth (%) : 16

blank

08

Brand Name : Alliance revenue - Lenvima

Lenvatinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Alliance revenue - Lenvima

arrow
Pharmtech & Ingredients
Not Confirmed

Lenvatinib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 960

2022 Revenue in Millions : 876

Growth (%) : 10

blank

09

Brand Name : Lenvima

Lenvatinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Lenvima

arrow
Pharmtech & Ingredients
Not Confirmed

Lenvatinib

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 286

2016 Revenue in Millions : 181

Growth (%) : 58

blank

10

Brand Name : Lenvima

Lenvatinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Lenvima

arrow
Pharmtech & Ingredients
Not Confirmed

Lenvatinib

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 468

2017 Revenue in Millions : 268

Growth (%) : 74%

blank